Company Overview of Aesgen Inc.
Aesgen, Inc. focuses on treating the side effects associated with cancer treatments. It offers Saforis oral suspension product, which is a phase three product candidate in development for treatment of oral mucositis. As of September 28, 2004, Aesgen, Inc. operates as a subsidiary of MGI Pharma Inc.
Key Executives for Aesgen Inc.
Similar Private Companies By Industry
|Kellbenx Inc.||United States|
|Protein Pathways, Inc.||United States|
|GyneConcepts Inc.||United States|
|Human BioSciences Inc.||United States|
|West Coast Fermentation Center, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Aesgen Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.